Heron Therapeutics, Inc.
Heron Therapeutics is a specialty pharma company focused on acute-care pain management with minimal political engagement and no material government revenue dependence.
BusinessWhat HRTX does
Heron develops and commercializes innovative IV pain management and anesthesia products, primarily for hospital and surgical settings. Revenue derives from specialty pharmaceutical sales to healthcare systems and providers, with no significant Medicare/Medicaid or government contract exposure.
12 months past · 3 months futureHRTX activity timeline
Lifetime Government AwardsHRTX federal contracts
HRTX doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding HRTX
Congressional TradesWho in Congress is trading HRTX
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting HRTXLive legislation impacting this stock
Political ProfileWhere HRTX sits in Washington
Heron has no active lobbying presence, zero politician trades, and no named legislative winners/losers. Stock movement driven by clinical trial data, FDA decisions, and commercial execution rather than political events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- Medicare drug price negotiation expansion
- FDA approval delays
Regulatory opportunities
- Expedited approval pathways (Breakthrough Therapy)
- Orphan drug incentives
Live signals + predictions for HRTX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades HRTX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord